60633-91-2

Basic information

• Product Name: 2-(broMoMethyl)benzaldehyde
• Synonyms: 2-(broMoMethyl)benzaldehyde
• CAS NO: 60633-91-2
• Molecular Formula: C₈H₇BrO
• Molecular Weight: 199.04458
• Mol File: 60633-91-2.mol
• Article Data: 24

Chemical Properties

• Boiling Point: 264.6°C at 760 mmHg
• Flash Point: 97.6°C
• Appearance: /
• Density: 1.524g/cm³
• Vapor Pressure: 0.0096mmHg at 25°C
• Refractive Index: 1.616
• Solubility: Dichloromethane, Methanol
• CAS DataBase Reference: 2-(broMoMethyl)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(broMoMethyl)benzaldehyde(60633-91-2)
• EPA Substance Registry System: 2-(broMoMethyl)benzaldehyde(60633-91-2)

Safety Data

• Hazardous Substances Data: 60633-91-2(Hazardous Substances Data)

Usage

Description

2-(Bromomethyl)benzaldehyde is an organic compound characterized by the presence of a bromomethyl group and a benzaldehyde moiety. It is a versatile intermediate in organic synthesis and has potential applications in various chemical and pharmaceutical processes.

Uses

Used in Chemical Synthesis:
2-(Bromomethyl)benzaldehyde is used as a key intermediate for the preparation of triiron complexes of PDK, a porphyrin-linked dicarboxylate ligand. This application is significant in the development of new materials and compounds with potential applications in various industries.
Used in Pharmaceutical Industry:
2-(Bromomethyl)benzaldehyde can be utilized as a building block in the synthesis of pharmaceutical compounds, particularly those with potential therapeutic properties. Its unique structure allows for the creation of novel drug candidates that can target specific biological pathways or receptors.
Used in Material Science:
In the field of material science, 2-(Bromomethyl)benzaldehyde can be employed in the development of new materials with unique properties. Its ability to form complexes with metal ions, such as triiron, can lead to the creation of advanced materials with potential applications in various sectors, including electronics, energy, and environmental technologies.

InChI:InChI=1/C8H7BrO/c9-5-7-3-1-2-4-8(7)6-10/h1-4,6H,5H2

Upstream product

• 22115-41-9 2-(bromomethyl)benzonitrile 
• 529-20-4 2-methylphenyl aldehyde 
• 31675-37-3 2-diacetoxymethyltoluene 
• 37803-24-0 o-Diacetoxymethyl-benzylbromid 

Downstream Products

• 138829-05-7 Bis(2-formylbenzyl)sulfide 
• 945996-01-0 N-1-(2-(bromomethyl)-benzyl)-3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)urea 
• 1186227-34-8 Boc-Cys((O)-2-CHOBn)-OEt 
• 96846-37-6 ethyl α-N-t-butoxycarbonyl-α,β-didehydroalaninate 
• 1218996-93-0 2-((naphthalen-2-yl)methyl)benzaldehyde 
• 1218996-94-1 2-((6-methoxynaphthalen-2-yl)methyl)benzaldehyde 
• 1338438-27-9 2-((2-oxothiazol-3(2H)-yl)methyl)benzaldehyde 
• 1384866-65-2 (E)-methyl 4-{2-[4-(dimethylamino)but-1-enyl]benzyloxy}-3-iodophenylacetate 
• 140462-76-6 olopatadine hydrochloride 
• 25473-60-3 2-benzyl-2H-isoindole 
• 1357471-68-1 2-(4-ethoxyphenyl)-2H-isoindole 
• 103411-97-8 2-(2-(bromomethyl)phenyl)-1,3-dioxolane 
• 1415042-64-6 N-[2-(1,3-Dioxolan-2-yl)benzyl]-N-ethylcyclopropanecarboxamide 
• 128174-77-6 2-phenyl-1,2-dihydrophthalazine 

Relevant articles and documents

Intracellular Generation of a Diterpene-Peptide Conjugate that Inhibits 14-3-3-Mediated Interactions

Synthetic agents that disrupt intracellular protein-protein interactions (PPIs) are highly desirable for elucidating signaling networks and developing new therapeutics. However, designing cell-penetrating large molecules equipped with the many functional

A Highly Fluorinated Chiral Aldehyde for Enantioselective Fluorescent Recognition in a Biphasic System

A 1,1′-bi-2-naphthol (BINOL)-based aldehyde containing four perfluoroalkyl groups has been designed and synthesized. It shows enantioselective fluorescence enhancement at 420 nm when treated with the enantiomers of trans-1,2-diaminocyclohexane in an organ

Compound with PPAR delta agonistic activity, pharmaceutical composition and medical application

The invention discloses a compound with PPAR delta agonistic activity, a pharmaceutical composition and medical application, wherein the structure of the compound is shown as a formula I in the specification. The compound shown in the formula I is a novel

An Intramolecular Cycloaddition Approach to the Kauranoid Family of Diterpene Metabolites

Synthetic studies toward the ent-kauranoid family of diterpene natural products are reported. An intramolecular (4 + 3) cycloaddition allows the direct elaboration of diverse natural product frameworks, encompassing a challenging bicyclo[3.2.1]octane core. The established routes comprise only a few synthetic operations (3-5 steps), transforming a range of simple starting materials into the tetracyclic scaffolds that are commonly found in many ent-kaurene metabolites.